Patient satisfaction with different botulinum toxin type A formulations in the treatment of moderate to severe upper facial rhytids

Journal of Cosmetic and Laser Therapy

Volumn 10, Issue 2, 2008, Pages 87-92

  De Boulle, Koen ^a  

^a Aalst Dermatology Group   (Belgium)

Author keywords

Botox; Botulinum toxin; Dysport; Rhytid

Indexed keywords

BOTULINUM TOXIN A;

ADULT; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG FORMULATION; DRUG PREFERENCE; DRUG TOLERABILITY; FACE MUSCLE; FEMALE; FOLLOW UP; FOREHEAD; HUMAN; HUMAN EXPERIMENT; INCIDENT REPORT; MALE; OUTCOME ASSESSMENT; PATIENT SATISFACTION; PERSONAL APPEARANCE; PRIORITY JOURNAL; QUESTIONNAIRE; WRINKLE;

ADULT; BOTULINUM TOXIN TYPE A; COSMETIC TECHNIQUES; CROSS-OVER STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PATIENT SATISFACTION; SKIN AGING;

EID: 45849098701     PISSN: 14764172     EISSN: 14764180     Source Type: Journal    
DOI: 10.1080/14764170701854679     Document Type: Article

References (16)

1. Smuts JA, de Boulle K, van Coller R, Barnard PWA. An electrophysiological study to demonstrate in vivo differences between two types of botulinum toxin type A (BOTOX® and DYSPORT®). Poster presented at the 8th International Congress of Parkinson's Disease and Movement Disorder, June 13-17, 2004, Rome, Italy.
2. Lowe P, Patnaik R, Lowe N. Comparison of two formulations of botulinum toxin type A for the treatment of glabellar lines: A double-blind, randomized study. J Am Acad Dermatol. 2006;55:975-80. Epub 2006 Oct 6.
3. Trindade de Almeida AR, Marques E, de Almeida J, Cunha T, Boraso R. Pilot study comparing the diffusion of two formulations of botulinum toxin type A in patients with forehead hyperhidrosis. Dermatol Surg. 2007;33(suppl 1):S37-43.
4. Cliff SH, Judodihardjo H, Eltringham E. Different formulations of botulinum toxin type A have different migration characteristics: a double-blind, randomized study. J Cosmet Dermatol. 2008;7:50-54.
5. Lew H, Yun YS, Lee SY, Kim SJ. Effect of botulinum toxin A on facial wrinkle lines in Koreans. Ophthalmologica. 2002;216:50-4.
6. Nüßgens Z, Roggenkamper P. Comparison of two botulinum-toxin preparations in the treatment of essential blepharospasm. Graefes Arch Clin Exp Ophthalmol. 1997;235:197-9.
7. Ranoux D, Gury C, Fondarai J, Mas JL, Zuber M. Respective potencies of Botox and Dysport: A double blind, randomised, crossover study in cervical dystonia. J Neurol Neurosurg Psychiatry. 2002;72:459-62.
8. Dodel RC, Kirchner A, Koehne-Volland R, Künig G, Ceballos-Baumann A, Naumann M, et al. Costs of treating dystonias and hemifacial spasm with botulinum toxin A. Pharmacoeconomics. 1997;12:695-706.
9. Simonetta Moreau M, Cauhepe C, Magues JP, Senard JM. A double-blind, randomized, comparative study of Dysport® vs. Botox® in primary palmar hyperhidrosis. Br J Dermatol. 2003;149:1041-5.
10. Roche N, Schnitzler A, Genêt F, Durand MC, Bensmail D. Uncontrolled migration outside the targeted muscle associated with adverse effect of botulinum toxin type A distant from the injection site: A preliminary analysis. Undesirable distant effects following botulinum toxin type-A injection. Clinical Neuropharmacology. 2008 (in press).
11. BOTOX® COSMETIC prescribing information, Accessed 13 February 2007. URL: http://www.botoxcosmetic.com/pi/pi.pdf.
12. Ascher B, Zakine B, Kestemont P, Baspeyras M, Bougara A, Santini J. A multicenter, randomized, double-blind, placebo-controlled study of efficacy and safety of 3 doses of botulinum toxin A in the treatment of glabellar lines. J Am Acad Dermatol. 2004;51:223-33.
13. Monheit G, Carruthers A, Brandt F, Rand R. A randomized, double-blind, placebo-controlled study of botulinum toxin type A for the treatment of glabellar lines: Determination of optimal dose. Dermatol Surg. 2007;33(1 Spec No.):S51-9.
14. Carruthers A, Carruthers J, Said S. Dose-ranging study of botulinum toxin type A in the treatment of glabellar rhytids in females. Dermatol Surg. 2005;31:414-22.
15. Cox SE, Finn JC, Stetler L, Mackowiak J, Kowalski JW. Development of the Facial Lines Treatment Satisfaction Questionnaire and initial results for botulinum toxin type A-treated patients. Dermatol Surg. 2003;29:444-9.
16. Stotland MA, Kowalski JW, Ray BB. Patient-reported benefit and satisfaction with botulinum toxin type A treatment of moderate to severe glabellar rhytides: results from a prospective open-label study. Plast Reconstr Surg. 2007;120;1386-93; discussion 1394.